395 results
-
Responsible Person survey for 24-month review of the Minimum Stockholding Requirements
Purpose of Survey: The Australian Department of Health and Aged Care (the department) is conducting a 24-month review of the outcomes and impacts of the Minimum Stockholding Requirements (MSR) policy that commenced on 1 July 2023 under Division 3CAA under the National Health Act 1953. We are seeking your input to the review through this online survey. This is the second survey of RPs on the MSR. The first survey, conducted in 2024 for the 12-month review,... MoreClosed 9 May 2025 -
Survey for the 24-month review of the Minimum Stockholding Requirements
Minimum Stockholding Requirements From 1 July 2023 minimum stockholding requirements (MSR) have applied to certain medicines listed on the Pharmaceutical Benefits Scheme (PBS) referred to as Designated Brands. The MSR is designed to help protect Australian patients, pharmacists, and prescribers from the impact of global medicines shortages. While these measures will not prevent shortages that are outside of the control of Australian companies, they will help to ensure that... MoreClosed 9 May 2025 -
National Health and Medical Research Strategy - Webinar 2 Survey
The National Health and Medical Research Strategy (National Strategy) will build on Australia’s strengths in health and medical research and world-leading research capability. It will aim to attract researchers and investors and improve health results in communities. Ms Rosemary Huxtable AO PSM, Chair of the National Strategy, held the second National Strategy online webinar (Webinar 2) on 7 April 2025. It provided an update on work to date to develop the National... MoreClosed 12 May 2025 -
Weekly Bed Vacancy Data Request - 9 May 2025
Please complete the data survey by close of business today. Please do not use any other to provide your data, as this impacts consolidation and analysis. This information will be submitted to the Tasmanian Health Service (THS) by end of day, Monday 12 May 2025. It will assist discharge discussions and pathways from acute care to aged care for older Tasmanians. MoreClosed 12 May 2025 -
DIR-215 Limited and controlled release of canola genetically modified for dairy protein production
The Gene Technology Regulator has received a licence application (DIR 215) from Miruku Australia Pty Ltd for a field trial of genetically modified (GM) canola. Comments are now being sought on the consultation version of the Risk Assessment and Risk Management Plan (RARMP) that has been prepared by the Office of the Gene Technology Regulator (OGTR). The draft RARMP and other relevant documents can be viewed in the related attachments below. Note: No... MoreOpened 2 April 2025
395 results.
Page 14 of 14